Comparison SAB Biotherapeutics (SABS) with Competitors
SAB Biotherapeutics (SABS) industry is Biotechnology.
Free Cash Flow Yield
SABS-19.39%
Industry-1.75%
Upside-17.64%
P/E
SABS14.14
Industry-20.52
Upside+3465.30%
P/S
SABS2.96
Industry10.01
Upside-70.45%
P/B
SABS1.21
Industry5.15
Upside-76.47%